Wong ANM - Search Results

1

Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand.

Walsh N, Stephens R, Tan A, Durandt V, McLachlan J, Jordan J, Gregory K, Sutton S, Barrow C, Wong ANM. Walsh N, et al. Among authors: wong anm. JCO Oncol Pract. 2024 Jul 25:OP2400208. doi: 10.1200/OP.24.00208. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39052949

2

Yuan Fen.

Wong ANM. Wong ANM. JCO Glob Oncol. 2022 May;8:e2200110. doi: 10.1200/GO.22.00110. JCO Glob Oncol. 2022. PMID: 35594495 Free PMC article. No abstract available.

3

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.

Parakh S, Park JJ, Mendis S, Rai R, Xu W, Lo S, Drummond M, Rowe C, Wong A, McArthur G, Haydon A, Andrews MC, Cebon J, Guminski A, Kefford RF, Long GV, Menzies AM, Klein O, Carlino MS. Parakh S, et al. Br J Cancer. 2017 Jun 6;116(12):1558-1563. doi: 10.1038/bjc.2017.142. Epub 2017 May 18. Br J Cancer. 2017. PMID: 28524161 Free PMC article.

4

Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancers.

Tiu C, Wong A, Herschtal A, Mileshkin L. Tiu C, et al. Asia Pac J Clin Oncol. 2018 Aug;14(4):337-342. doi: 10.1111/ajco.12867. Epub 2018 Mar 1. Asia Pac J Clin Oncol. 2018. PMID: 29498208

5

Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death-1 monoclonal antibodies for advanced melanoma.

Wong A, Williams M, Milne D, Morris K, Lau P, Spruyt O, Fullerton S, McArthur G. Wong A, et al. Asia Pac J Clin Oncol. 2017 Dec;13(6):385-390. doi: 10.1111/ajco.12702. Epub 2017 Jun 29. Asia Pac J Clin Oncol. 2017. PMID: 28661584

6

The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.

Wong ANM, McArthur GA, Hofman MS, Hicks RJ. Wong ANM, et al. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):67-77. doi: 10.1007/s00259-017-3691-7. Epub 2017 Apr 7. Eur J Nucl Med Mol Imaging. 2017. PMID: 28389693 Review.

7

Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?

Wong A, Billett A, Milne D. Wong A, et al. Oncologist. 2019 Nov;24(11):e1190-e1196. doi: 10.1634/theoncologist.2018-0820. Epub 2019 Apr 23. Oncologist. 2019. PMID: 31015314 Free PMC article.

8

¹⁸F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma.

Wong A, Callahan J, Keyaerts M, Neyns B, Mangana J, Aberle S, Herschtal A, Fullerton S, Milne D, Iravani A, McArthur GA, Hicks RJ. Wong A, et al. Cancer Imaging. 2020 May 14;20(1):36. doi: 10.1186/s40644-020-00313-2. Cancer Imaging. 2020. PMID: 32408884 Free PMC article.

9

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.

Menzies AM, Johnson DB, Ramanujam S, Atkinson VG, Wong ANM, Park JJ, McQuade JL, Shoushtari AN, Tsai KK, Eroglu Z, Klein O, Hassel JC, Sosman JA, Guminski A, Sullivan RJ, Ribas A, Carlino MS, Davies MA, Sandhu SK, Long GV. Menzies AM, et al. Among authors: wong anm. Ann Oncol. 2017 Feb 1;28(2):368-376. doi: 10.1093/annonc/mdw443. Ann Oncol. 2017. PMID: 27687304 Free article.

10

Differential kinetics of response and toxicity using stereotactic radiation and interventional radiological coiling for pulmonary arterio-venous shunting from metastatic leiomyosarcoma.

Wong ANM, Siva S, Manser R, Dowling R, Antippa P, Chin K, Mileshkin LR. Wong ANM, et al. J Med Imaging Radiat Oncol. 2015 Aug;59(4):486-488. doi: 10.1111/1754-9485.12307. Epub 2015 Apr 23. J Med Imaging Radiat Oncol. 2015. PMID: 25906674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters